Cytokine antagonists for the treatment of asthma: progress to date.
about
Pitrakinra for asthma.Monoclonal antibodies for asthma and chronic obstructive pulmonary disease.Benralizumab as a potential treatment of asthma.Combined use of pharmacophoric models together with drug metabolism and genotoxicity "in silico" studies in the hit finding process.Pharmacologic modulation of experimentally induced allergic asthma.Nebulized anti-IL-13 monoclonal antibody Fab' fragment reduces allergen-induced asthma.
P2860
Cytokine antagonists for the treatment of asthma: progress to date.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cytokine antagonists for the treatment of asthma: progress to date.
@en
Cytokine antagonists for the treatment of asthma: progress to date.
@nl
type
label
Cytokine antagonists for the treatment of asthma: progress to date.
@en
Cytokine antagonists for the treatment of asthma: progress to date.
@nl
prefLabel
Cytokine antagonists for the treatment of asthma: progress to date.
@en
Cytokine antagonists for the treatment of asthma: progress to date.
@nl
P2860
P1433
P1476
Cytokine antagonists for the treatment of asthma: progress to date.
@en
P2860
P304
P356
10.2165/11317130-000000000-00000
P577
2009-01-01T00:00:00Z
P6179
1006093108